FFTY ETF Explained: Returns, Expense Ratio, Holdings and Alternative ETFs
The Capfos IBD 50 ETF (FFTY) invests in 50 US growth stocks selected on earnings growth and momentum. It is a growth-theme ETF worth a look for aggressive investors who want to weigh the outlook for growth stocks alongside diversification across related names.
SubscribeWhat Is the Capfos IBD 50 ETF?
This is a growth-focused ETF that tracks the IBD 50 index. It selects US-listed companies with strong earnings growth and price relative strength using a rules-based approach, and it is managed by refreshing its holdings on a regular schedule.
It suits aggressive investors who are willing to accept high volatility in exchange for concentrated exposure to growth stocks.
It is an actively managed ETF run by Capfos.
How Does the Capfos IBD 50 ETF Invest?
| Item | Details |
|---|---|
| Tracked Index | IBD 50 |
| Management Style | Rules-based active (growth and momentum selection) |
| Rebalancing Frequency | Regular updates |
| Dividend Frequency | Annual dividend |
| Issuer | Capfos |
| Expense Ratio | 0.80% |
The fund screens US-listed growth stocks using growth indicators such as earnings growth rate, profitability, and price relative strength, and holds them in a concentrated portfolio. Because additions and removals are reflected regularly under the index rules, stock concentration and turnover tend to be higher than in broad market ETFs.
- Stock selection based on growth and momentum indicators
- A concentrated portfolio focused on growth stocks
Capfos IBD 50 ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $57.7M, and the total expense ratio (Expense Ratio) is 0.80% per year.
Compared with broad factor ETFs, the fund holds fewer stocks and is concentrated in growth names, so performance can vary widely depending on the market environment.
Capfos IBD 50 ETF Performance and Trends
1-Year Price Performance
Dividend & Yield
52-Week Price RangeThe fund tends to show relatively strong performance when appetite for growth stocks is high, while volatility tends to widen when interest rates rise or investors turn risk averse. Given its growth-theme nature, its price swings are larger than those of the overall market.
It belongs to a category where fund flows react sensitively to investor sentiment toward growth stocks. Because it is a concentrated growth portfolio, its asset size can fluctuate more than that of a broad core ETF.
Capfos IBD 50 ETF Pros and Cons
Concentrated exposure to growth stocks is its strength, but high volatility and stock concentration risk should be weighed as drawbacks.
💪 Key Strengths
⚠️ Points to Watch
Alternative ETFs and Related Products to the Capfos IBD 50 ETF
The fundamental factor ETFs shown together in the table weight stocks by financial metrics, making them alternatives with lower concentration in any specific growth theme. If you want to capture the same growth and momentum tilt more broadly, you can also consider MTUM, a momentum factor ETF, and large-cap growth products such as IWF, VUG, and SCHG as comparison candidates.
Peer Comparison ETFs| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
 FNDX | Schwab Fundamental U.S. Large Company ETF | $32.60 | -0.6% | $28.5B | 0.25% | 1.45% | +22.7% |
 PRF | Invesco RAFI US 1000 ETF | $56.05 | -0.6% | $10.1B | 0.34% | 1.32% | +22.9% |
 FNDA | Schwab Fundamental U.S. Small Company ETF | $35.67 | -0.5% | $8.9B | 0.25% | 1.24% | +14.1% |
 RECS | Columbia Research Enhanced Core ETF | $45.30 | -0.5% | $6.2B | 0.15% | 0.72% | +12.7% |
 JHMM | John Hancock Multifactor Mid Cap ETF | $72.79 | -0.6% | $6.0B | 0.41% | 0.9% | +11.9% |
Top Holdings| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
 MIRM | Mirum Pharmaceuticals Inc | 0.04% | $80.39 | -3.3% | $5.2B | - | - |
| MU | Micron Technology Inc | 0.04% | $877.55 | +2.5% | $992.9B | 11.8 | 0.08% |
 ANAB | AnaptysBio Inc | 0.04% | $48.73 | +1.3% | $1.5B | 7.6 | - |
| FIX | Comfort Systems USA Inc | 0.04% | $1160.86 | -9.3% | $40.9B | 25.1 | 0.28% |
 FTAI | FTAI Aviation Ltd | 0.03% | $154.37 | -2.0% | $15.9B | 33.6 | 1.24% |
 IAG | Iamgold Corp | 0.03% | $16.26 | -1.0% | $9.3B | 8.2 | - |
 PACS | PACS Group Inc | 0.03% | $47.64 | +0.3% | $7.5B | 28.6 | - |
| RKLB | Rocket Lab Corp | 0.03% | $52.60 | +2.7% | $31.5B | - | - |
| CLS | Celestica Inc | 0.03% | $260.01 | -3.4% | $32.8B | 27.0 | - |
 CDE | Coeur Mining Inc | 0.03% | $13.45 | -3.1% | $13.8B | 11.1 | 0.3% |
Capfos IBD 50 ETF Investor Checkpoints
Here are the points to review before investing in FFTY. Since this is a product concentrated in growth stocks, it is important to thoroughly check its volatility, stock concentration, and cost structure in advance, and to confirm that it fits your investment style and risk tolerance.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 💵 Expense Ratio | Check the cumulative cost impact over a long holding period | Somewhat high |
| 📊 Stock Concentration | Weights of individual stocks in the concentrated portfolio | High concentration |
| 📈 Volatility | Check price swings across market phases | High volatility |
| 💱 Exchange Rate | Impact on returns converted to Korean won | Not currency-hedged |
Concentration in growth stocks and high turnover are the main drivers of short-term volatility. In risk-averse phases, losses can exceed those of the broader market, so it is necessary to approach the fund while managing its weight within your overall assets.
This is a thematic ETF worth considering for investors who want active exposure to growth stocks. If the volatility is a burden, it is advisable to compare it with broad factor ETFs or large-cap growth ETFs before choosing.
SubscribeDisclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of July 2, 2026.
Today's 5 AI picks, all free